Last updated: June 20, 2018

E.U. Agency in Limbo as Hidden Costs of ‘Brexit’ Continue to Mount

The likely move of the European Medicines Agency, currently in Britain, has worrying implications for the country’s vibrant biotech and pharmaceuticals sector.
NYT > Europe

Keywords: , , , , , , ,

Readers Comments (0)

Sorry, comments are closed on this post.

Recent Posts

Have You Read?

Video News